FR-290581

N/A

Report date: 2024/12/04 15:17:57
NME

Base Information

Drug NameFR-290581
Drug Alias NameFR-290581
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionElongation factor 2 inhibitors
TargetsElongation factor 2
Therapy Area/IndicationsMycoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma Inc
Active IndicationsN/A
Inactive IndicationsMycoses

Other Information

ATC CodeN/A
Related LinksN/A